NASDAQ:DRAD - Digirad Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.60 -0.05 (-3.03 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$1.65
Today's Range$1.60 - $1.65
52-Week Range$1.25 - $4.15
Volume39,100 shs
Average Volume65,634 shs
Market Capitalization$32.69 million
P/E RatioN/A
Dividend Yield13.54%
Digirad logoDigirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.

Receive DRAD News and Ratings via Email

Sign-up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Electromedical equipment


Debt-to-Equity Ratio0.42
Current Ratio1.62
Quick Ratio1.20


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$118.34 million
Price / Sales0.27
Cash Flow$0.6957 per share
Price / Cash2.30
Book Value$1.39 per share
Price / Book1.15


EPS (Most Recent Fiscal Year)N/A
Net Income$-35,730,000.00
Net Margins-25.76%
Return on Equity-2.36%
Return on Assets-1.28%


Outstanding Shares20,120,000
Market Cap$32.69

The Truth About Cryptocurrencies

Digirad (NASDAQ:DRAD) Frequently Asked Questions

What is Digirad's stock symbol?

Digirad trades on the NASDAQ under the ticker symbol "DRAD."

How often does Digirad pay dividends? What is the dividend yield for Digirad?

Digirad announced a quarterly dividend on Wednesday, May 2nd. Investors of record on Tuesday, May 15th will be paid a dividend of $0.055 per share on Wednesday, May 30th. This represents a $0.22 annualized dividend and a yield of 13.75%. The ex-dividend date of this dividend is Monday, May 14th. View Digirad's Dividend History.

How were Digirad's earnings last quarter?

Digirad Co. (NASDAQ:DRAD) released its quarterly earnings results on Tuesday, May, 1st. The medical equipment provider reported ($0.07) EPS for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.06. The medical equipment provider had revenue of $25.47 million for the quarter. Digirad had a negative net margin of 25.76% and a negative return on equity of 2.36%. View Digirad's Earnings History.

When is Digirad's next earnings date?

Digirad is scheduled to release their next quarterly earnings announcement on Friday, August, 3rd 2018. View Earnings Estimates for Digirad.

What price target have analysts set for DRAD?

1 brokers have issued twelve-month price targets for Digirad's shares. Their predictions range from $6.00 to $6.00. On average, they expect Digirad's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 275.0% from the stock's current price. View Analyst Ratings for Digirad.

What is the consensus analysts' recommendation for Digirad?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Digirad in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Digirad's key competitors?

Who are Digirad's key executives?

Digirad's management team includes the folowing people:
  • Mr. Matthew Gabel Molchan, Pres, CEO, Interim CFO & Director (Age 51)
  • Mr. Martin B. Shirley, Pres of Digirad Imaging Solutions (Age 56)
  • Mr. Virgil J. Lott, Pres of Diagnostic Imaging (Age 60)
  • Mr. James M. Portwood, VP of Operations
  • Mr. Bob Halbert, Sr. Director of Human Resource

Has Digirad been receiving favorable news coverage?

News headlines about DRAD stock have been trending somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Digirad earned a news impact score of 0.09 on Accern's scale. They also assigned news headlines about the medical equipment provider an impact score of 46.32 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Digirad's major shareholders?

Digirad's stock is owned by a number of of retail and institutional investors. Top institutional investors include CANNELL CAPITAL LLC (10.76%) and CANNELL CAPITAL LLC (10.76%). Company insiders that own Digirad stock include Cannell Capital Llc, Jeffrey E Eberwein, Jeffry R Keyes, Matthew G Molchan, Michael A Cunnion and Virgil Lott. View Institutional Ownership Trends for Digirad.

How do I buy shares of Digirad?

Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Digirad's stock price today?

One share of DRAD stock can currently be purchased for approximately $1.60.

How big of a company is Digirad?

Digirad has a market capitalization of $32.69 million and generates $118.34 million in revenue each year. Digirad employs 515 workers across the globe.

How can I contact Digirad?

Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at [email protected]

MarketBeat Community Rating for Digirad (NASDAQ DRAD)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  226 (Vote Outperform)
Underperform Votes:  162 (Vote Underperform)
Total Votes:  388
MarketBeat's community ratings are surveys of what our community members think about Digirad and other stocks. Vote "Outperform" if you believe DRAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.